ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0922

Phenotypic and Transcriptomic Divergence in C3 Glomerular Mouse Models: Insights into Immune and Sex Correlates

Juan Liang1 and kaiyuan zi2, 1Gempharmatech, Nanjing, Jiangsu, China, 2Gempharmatech, Nanjing, Jiangsu, Jiangsu, China

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, complement, Mouse Models, Other, Nephritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0916–0933) Innate Immunity Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Complement component C3 plays a central role in the alternative pathway (AP) and is implicated in the pathogenesis of C3 glomerulopathy (C3G), a rare renal disease. To model human-specific complement dysregulation, we developed two humanized C3 mouse models: B6-hC3 (expressing human C3 transgene) and B6-hC3 mC3 KO (expressing human C3 transgene with knockout of mouse C3). These models were designed to induce unregulated C3 activation via the alternative pathway (AP) and recapitulate C3G-like phenotypes. Through phenotypic assessment and RNA sequencing, we sought to elucidate molecular mechanisms underlying disease development and investigate sex-associated gene expression signatures.

Methods: A human C3 transgene was introduced into B6 mouse embryos to generate B6-hC3 mice. Additionally, the endogenous mouse C3 gene in B6-hC3 mice was knocked out to generate B6-hC3 mC3 KO mice. Both B6-hC3 and B6-hC3 mC3 KO mice were evaluated longitudinally for renal dysfunction via urinalysis. RNA sequencing (RNA-seq) was performed on both B6-hC3 and B6-hC3 mC3 KO mice to identify differentially expressed genes and pathways between strains and sexes.

Results: Both B6-hC3 and B6-hC3 mC3 KO strains developed hallmark features of C3G. However, B6-hC3 mC3 KO mice exhibited more severe renal dysfunction and damage compared to B6-hC3. Notably, female B6-hC3 mC3 KO mice developed higher levels of proteinuria and exhibit diverse renal lesions compared to males, suggesting sex-specific susceptibility. RNA-seq analysis revealed strain-specific transcriptomic profiles between B6-hC3 and B6-hC3 mC3 KO strains, as well as sex-associated gene expression signatures between male and female B6-hC3 mC3 KO mice.

Conclusion: In this study, two novel humanized mouse models that recapitulate key features of human C3G were established. Phenotypic and transcriptomic analyses reveal critical differences between strains and sex, making these models valuable platforms for future mechanistic studies of C3G and for the preclinical evaluation of targeted complement-modulating therapies.


Disclosures: J. Liang: None; k. zi: None.

To cite this abstract in AMA style:

Liang J, zi k. Phenotypic and Transcriptomic Divergence in C3 Glomerular Mouse Models: Insights into Immune and Sex Correlates [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/phenotypic-and-transcriptomic-divergence-in-c3-glomerular-mouse-models-insights-into-immune-and-sex-correlates/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/phenotypic-and-transcriptomic-divergence-in-c3-glomerular-mouse-models-insights-into-immune-and-sex-correlates/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology